Bacterial infections in cirrhosis: A critical review and practical guidance

被引:17
|
作者
Chalermrat Bunchorntavakul [1 ]
Naichaya Chamroonkul [2 ]
Disaya Chavalitdhamrong [3 ]
机构
[1] Division of Gastroenterology and Hepatology, Department of Internal Medicine, Rajavithi Hospital, College of Medicine, Rangsit University
[2] Division of Gastroenterology and Hepa-tology, Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University
[3] Division of Gastroenterology,Department of Internal Medicine, Harbor--UCLA Medical
关键词
Bacteria; Infection; Sepsis; Bacteremia; Liver cirrhosis; Vaccination; Spontaneous peritonitis; Immune dysfunction;
D O I
暂无
中图分类号
R575.2 [肝硬变];
学科分类号
1002 ; 100201 ;
摘要
Bacterial infection is common and accounts for major morbidity and mortality in cirrhosis. Patients with cirrhosis are immunocompromised and increased susceptibility to develop spontaneous bacterial infections, hospital-acquired infections, and a variety of infections from uncommon pathogens. Once infection develops, the excessive response of pro-inflammatory cytokines on a pre-existing hemodynamic dysfunction in cirrhosis further predispose the development of serious complications such as shock, acute-on-chronic liver failure, renal failure, and death. Spontaneous bacterial peritonitis and bacteremia are common in patients with advanced cirrhosis, and are important prognostic landmarks in the natural history of cirrhosis. Notably, the incidence of infections from resistant bacteria has increased significantly in healthcare-associated settings. Serum biomarkers such as procalcitonin may help to improve the diagnosis of bacterial infection. Preventive measures(e.g., avoidance, antibiotic prophylaxis, and vaccination), early recognition, and proper management are required in order to minimize morbidity and mortality of infections in cirrhosis.
引用
收藏
页码:307 / 321
页数:15
相关论文
共 50 条
  • [41] Novel prevention strategies for bacterial infections in cirrhosis
    Yan, Kathleen
    Garcia-Tsao, Guadalupe
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (05) : 689 - 701
  • [42] Diagnosis and management of bacterial infections in decompensated cirrhosis
    Maria Pleguezuelo
    Jose Manuel Benitez
    Juan Jurado
    Jose Luis Montero
    Manuel De la Mata
    World Journal of Hepatology, 2013, (01) : 16 - 25
  • [43] IMPACT OF RIFAXIMIN IN THE PREVENTION OF BACTERIAL INFECTIONS IN CIRRHOSIS
    Mariani, M.
    Scudeller, L.
    Patruno, S. F. A.
    Zuccaro, V.
    Columpsi, P.
    Toppino, S.
    Malfitano, A.
    Parisi, A.
    Filice, G.
    Bruno, R.
    DIGESTIVE AND LIVER DISEASE, 2015, 47 : E53 - E54
  • [44] PRACTICAL MANAGEMENT OF OCULAR INFECTIONS .1. BACTERIAL INFECTIONS
    DEVOE, AG
    CANADIAN JOURNAL OF OPHTHALMOLOGY, 1972, 7 (01): : 3 - &
  • [45] Nanoparticles approach to eradicate bacterial biofilm-related infections: A critical review
    Al-Wrafy, Fairoz Ali
    Al-Gheethi, Adel Ali
    Ponnusamy, Senthil Kumar
    Noman, Efaq Ali
    Fattah, Shaima Abdul
    CHEMOSPHERE, 2022, 288
  • [46] Bacterial bloodstream infections in critical patients
    Sabatier, C.
    Peredo, R.
    Valles, J.
    MEDICINA INTENSIVA, 2009, 33 (07) : 336 - 345
  • [47] Unresolved issues in the prophylaxis of bacterial infections in patients with cirrhosis
    Melisa Dirchwolf
    Sebastián Marciano
    José Martínez
    Andrés Eduardo Ruf
    World Journal of Hepatology, 2018, (12) : 892 - 897
  • [48] Spontaneous bacterial peritonitis and extraperitoneal infections in patients with cirrhosis
    Mattos, Angelo A.
    Wiltgen, Denusa
    Jotz, Raquel F.
    Dornelles, Caroline M. R.
    Fernandes, Matheus V.
    Mattos, Angelo Z.
    ANNALS OF HEPATOLOGY, 2020, 19 (05) : 451 - 457
  • [49] The impact of bacterial infections on survival of patients with decompensated cirrhosis
    Strauss, Edna
    ANNALS OF HEPATOLOGY, 2014, 13 (01) : 7 - 19
  • [50] Bacterial infections in patients with cirrhosis: reasons, comments and suggestions
    Navasa, M
    DIGESTIVE AND LIVER DISEASE, 2001, 33 (01): : 9 - 12